RYTHM, Inc.(RYM)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$13.51
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for RYM

11/13/2026: RYM (1-star) is currently NOT-A-BUY. Pass it for now.

RYTHM, Inc. is a small-cap consumer-facing company that has recently transitioned from indoor agriculture technology to a portfolio of cannabis and hemp-derived THC brands. The company's main strength lies in its recognized brand portfolio and access to retail channels for its THC beverages. Its primary investment story hinges on successfully scaling these consumer brands in a growing market. However, investors face material risks including significant operating losses, high debt levels, and regulatory uncertainty surrounding THC products. This stock is generally suited for aggressive investors willing to tolerate high volatility, with the company's ability to achieve profitability being the most critical development to monitor.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company's pivot to consumer brands offers growth potential, but execution risks are significant.
Momentum investorWeak fitThe stock has experienced significant volatility and downward pressure over the past year.
Value investorWeak fitCurrent valuations are speculative given the company's ongoing net losses and lack of stable earnings.
Dividend investorWeak fitThe company does not pay dividends and is currently focused on capital preservation and growth.
Low-risk investorWeak fitThe company's micro-cap status, high debt, and industry volatility make it unsuitable for low-risk portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is subject to extreme price swings typical of small-cap cannabis companies.
Valuation riskHighUncertain earnings visibility makes it difficult to anchor the company's true value.
Competition risk (Cannabis/THC)HighIntense competition from well-capitalized MSOs threatens market share growth.
Business qualityMediumThe company is in the early stages of proving its new consumer-branded business model.
Dividend incomeLow / noneNo dividend payments are expected in the near term.
Execution riskHighSuccessfully managing a portfolio of licensed brands requires precise operational execution.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 29.45M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 19.3K shares
Beta 9.93
52 Weeks Range 12.53 - 37.34
Updated Date 11/14/2026
52 Weeks Range 12.53 - 37.34
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) -5.08

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Tobacco

BUY participation
100.0%
Active BUY / eligible
3 / 3
30-Day BUY Count Change
+1

Eligible universe: 3 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit 128.93%
Avg. Invested days 12
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
RYM receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
RYM has moderate overall fundamentals (3 stars), with soft financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, solid earnings growth (+20.3%) and strong revenue growth (+78.5%) are partially offset by weak cash generation (FCF margin -136.2%), weak profitability (net margin -192.4%).

Financial Health Rating

★★★★★
RYM's financial health is soft, with the relatively strongest area being soft liquidity, including working-capital and asset support (WC/assets 4.3%). Overall financial-health metrics support a 2-star score.

Growth Momentum Score

★★★★★
Revenue growth is RYM's strongest growth driver at +78.5% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+20.3%, solid) is also solid, while free-cash-flow growth (-103.1%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 11.0% and approximately 54.7% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 45.96% supports management-shareholder alignment.

Top 5 Institutional Investors

Vanguard Capital Management, LLC 2.07%
IEQ CAPITAL, LLC 1.60%
Geode Capital Management, LLC 0.63%
Tidal Investments LLC. 0.57%
CI Private Wealth LLC 0.44%

Unit Economics (Per $1K Revenue)

★★★★★
RYM generates approximately $590 of gross profit, $-1,381 of operating income, and $-1,362 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 4.27%

Quantitative Style Profile

★★★★★
RYM has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Branded Product LicensingLicensing of brand intellectual property to third-party manufacturers.Revenue is largely driven by the company's ability to license its recognized brand names.
THC Beverage SalesDirect and retail sales of hemp-derived THC drinks like Señorita.The company is betting on consumer demand for THC alternatives to alcohol.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 63.60M
Price to Sales(TTM) 0.42
Enterprise Value 63.60M
Price to Sales(TTM) 0.42
Enterprise Value to Revenue 0.9
Enterprise Value to EBITDA 56.38
Shares Outstanding 2.18M
Shares Floating 1.19M
Shares Outstanding 2.18M
Shares Floating 1.19M
Percent Insiders 45.96
Percent Institutions 10.99

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.